Partner Article
Northwich Veterinary pharmaceutical company report gross profit up 5%
Northwich based veterinary pharmaceutical business Dechra Pharmaceuticals PLC report gross profit is up 5% at £56.9 million.
The cheshire based company released its half yearly report today, reporting strong revenue growth however profits have been influenced by strong currency headwinds.
The company report that currency problems will continue to affect its financial performance throughout the year.
The group have continued its expansion plans opening in Italy in March 2014 and begining trading in Canada in January 2015.
Chief Executive Officer, Ian Page, said: “The Group has made a solid start to the year with continued momentum in Europe and a strong performance in the US.
“Our focus on executing our strategy is delivering value to shareholders.
“Our core portfolio demonstrates growth, our product pipeline is delivering results and our global expansion is progressing well.”
This was posted in Bdaily's Members' News section by Sophia Taha .
What new NPPF rules mean for landowners
The hidden cost squeezing Britain's economy
Teesside deserves more than cashback devolution
Construction must be built on commercial discipline
Devolution needs financial firepower to drive growth
The value of creating a stronger careers route
Apprenticeships: Invest in talent or keep chasing it
Are you ready for salary transparency?
Confidence the key to our artificial intelligence future
The missing piece of the puzzle in the NEET crisis
The North East investment story needs two engines
We must forge change to close the skills gap